We recently reported the rational design, synthesis, and structural characterization of the most potent and selective peptide‐based neurokinin A antagonist thus far described: cyclo(Met1‐Asp2‐Trp3‐Phe4‐Dap5‐Leu6)cyclo(2β‐5β). Its bicyclic structure is characterized by a type I and a type II two β‐turn around Trp3‐Phe4 and Leu6‐Met1, respectively. In order to understand whether the two different β‐turned structures are determined by the bicyclic structure or by the amino acid type at the corner positions, we have synthesized the pseudosymmetrical analogue cyclo(Phe1‐Asp2‐Trp3‐Phe4‐Dap5‐Trp6)cyclo(2β‐5β). The structural characterization in the crystal state and in solution, here reported, gives an experimental evidence that the backbone of the bicyclic structure is a rigid scaffold that can be used to build both a type I and type II β‐turn independently from the amino acid composition. © 1997 John Wiley & Sons, Inc. Biopoly 40: 505–518, 1996